We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
National Commission is seeking evidence to shape regulation of AI in healthcare and support the UK’s ambition for a world-leading, AI-enabled NHS
The Mental Health Bill has received Royal Assent to modernise outdated mental health laws and improve care for seriously ill patients.
This is a collection of the community updates for the Infected Blood Memorial Committee
Updated MHRA guidance will help health institutions, such as NHS Trusts and Boards, safely design and make general medical devices for patients.
Times and days the CIC Office is open for business.
Sign up to our mailing list for updates on the Infected Blood Memorial Committee
Information on the change of vaccine for the routine adult pneumococcal vaccination programme and individuals at increased clinical risk.
Precision treatments tackling the hardest-to-treat cancers set to be produced from hundreds of tonnes of reprocessed uranium from nuclear reactors
Exploring the MHRA's transformational impact on access, experience, and outcomes.
New changes will enable patients to access urgent care easier.
A new referral service will connect victims with help through their GP, and there's up to £50 million for therapeutic support for child victims of sexual abuse.
There will be a national service of remembrance at St. Paul’s Cathedral for the infected blood community. This will be on Tuesday 19 May 2026.
As with any medicine, the MHRA will keep the safety and effectiveness of depemokimab under close review.
As with any medicine, the MHRA will keep the safety and effectiveness of fluticasone propionate under close review.
This holiday season, the MHRA is reminding people that some common festive foods can interact with medicines, altering how well they work or increasing the risk of side effects.
Professor Benger’s leadership comes at a pivotal time as the MHRA and NICE deepen collaboration
The government has accepted advice on eligibility from the Joint Committee on Vaccination and Immunisation (JCVI) for the spring 2026 COVID-19 vaccination programme.
Patients in the UK and Singapore could gain faster access to cutting-edge healthcare innovations under a new partnership bringing two globally respected regulators together with one of the world’s leading biotech creators.
Professor Anthony Harnden has congratulated the trio of Agency board members on the extension of their appointments.
As with any medicine, the MHRA will keep the safety and effectiveness of mirdametinib under close review.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).